Janney Montgomery Scott
ELI

Janney Montgomery Scott’s ELITE PHARMACEUTICAL ELI Stock Holding History

Janney Montgomery Scott’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-75,000
Closed -$24.1K – 2446
2014
Q3 		$24.1K Hold
75,000
– – ﹤0.01% 2252
2014
Q2 		$31.9K Hold
75,000
– – ﹤0.01% 2186
2014
Q1 		$30.7K Buy
+75,000
New +$30.7K ﹤0.01% 2012

Other funds holding ELI

GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return

Janney Montgomery Scott's ELI Position: Q4 2014 in Review

Janney Montgomery Scott sold out of ELITE PHARMACEUTICAL (ELI) in Q4 2014, closing a stake of 75,000 shares — an estimated $24.1K sold.

Janney Montgomery Scott first reported a position in ELI in Q1 2014 and held it in 3 quarters. The position peaked at $31.9K in Q2 2014. 4 funds tracked by Wall St. Rank hold ELI as of Q4 2014.

  • Janney Montgomery Scott reported no remaining ELITE PHARMACEUTICAL position as of Q4 2014 after selling out during the quarter.
  • Janney Montgomery Scott sold 75,000 ELITE PHARMACEUTICAL shares in Q4 2014, an estimated $24.1K.
  • Janney Montgomery Scott first reported a position in ELITE PHARMACEUTICAL in Q1 2014 and held it in 3 quarters.
  • Janney Montgomery Scott's ELITE PHARMACEUTICAL position peaked at $31.9K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q4 2014.

Based on Janney Montgomery Scott's 13F filing for Q4 2014, filed 10 Feb 2015.